<html><head><title>Barbara Weber cancer</title>
<meta http-equiv="Content-Type" content="text/html">
<meta http-equiv="Author" name="Barbara Weber" content="cancer">
<meta http-equiv="Author" name="cancer" content="breast">
<meta name="Language" content="de-en">
<meta name="Keywords" lang="de" content="cancer, Barbara Weber, breast">
<meta name="Keywords" lang="en" content="Barbara Weber, cancer, , breast">
<meta name="Description" lang="al "content=" . (Cited in 70 publications through August 1996) Comments by Barbara L. Weber, University of Pennsylvania When a team led by University of Utah geneticist Mark Skolnick announced the discovery of a breast-cancer susceptibility gene (Y. But three of the competing teams that were chasing after the same gene made their mark by publishing papers that confirmed the Skolnick squad's result. In addition to verifying its link to breast or ovarian cancer, or both, the Nature Genetics papers discussed the difficulty in developing a reliable screening test because the gene can mutate in so many ways.">
<meta name="Revisit-after" content="1 month">
<meta name="Date_modified" content="1900-1-">
<meta name="ROBOTS" content="index,follow">
</head>
<style type="text/css"> 
	A.nav:link {TEXT-DECORATION: none}
	A.nav:visited {TEXT-DECORATION: none} 
	A.nav:visited {TEXT-DECORATION: none}
	A.nav:active {TEXT-DECORATION: none}
	A.nav:hover {TEXT-DECORATION: none}
	</style><body bgcolor="#FFFFF">
	<font face="arial" size="3" color="#000000">
	<table border="0" cellpadding="0" cellspacing="0" width="100%">
	<tr><td><a href="breast.html" class="nav">breast</a></td></tr>
	<tr><td><a href="index.html" class="nav">home page</a></td></tr></table>
	<br><div align="center"><font size="6">- cancer -<br><br></font></div>
<table width="100%" border="0" cellspacing="3" cellpadding="6"
<td valign="top">
 Bixby Professor and Chairman Department of Surgery Washington University School of Medicine Robert Wittes, M. . of Population Science Fox Chase Cancer Center Wylie Burke, M. Associate Professor of Medicine Director of Women's Health Care Center University of Washington Francis S. Director, Center for Human Genome Research National Institutes of Health Joseph Fraumeni, M.</td>
<td valign="top"><img height=150 width=150 src="http://212.72.167.240/media/book.gif"></td>
<tr>
</table>
<table width="100%" border="0" cellspacing="3" cellpadding="1"
<td valign="top">
 She is the chair of the Steering Committee for the NCI-sponsored Cancer Genetics Network, a consortium of eight cancer genetics centers selected by competitive application, and she is a member of the Steering Committee of the International Breast Cancer Linkage Consortium. . Weber, an international leader in the field of breast cancer genetics, is a Professor of Medicine and Genetics at the University of Pennsylvania. She developed the Breast Cancer Program at the University of Pennsylvania Cancer Center in 1995 and has served as the director since that time. In this capacity, she implemented and directs the Breast Cancer Risk Evaluation Program, a clinical service designed to provide comprehensive risk assessment and counseling services to women concerned about their risk of developing breast cancer, with a special focus on women with a strong family history of breast cancer.</td>
<td valign="top"><img height="300" width="600" src="http://www.kampnagel.de/programm/produktionen/media06/Weber.jpg"></td>
<tr>
</table>
<table width="100%" border="0" cellspacing="3" cellpadding="4">
<td valign="top">
 . (Cited in 70 publications through August 1996) Comments by Barbara L. Weber, University of Pennsylvania When a team led by University of Utah geneticist Mark Skolnick announced the discovery of a breast-cancer susceptibility gene (Y. But three of the competing teams that were chasing after the same gene made their mark by publishing papers that confirmed the Skolnick squad's result. In addition to verifying its link to breast or ovarian cancer, or both, the Nature Genetics papers discussed the difficulty in developing a reliable screening test because the gene can mutate in so many ways.</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="1" cellpadding="3">
<td valign="top">
 Discussion Panels Meeting (The panels will meet for 30 minutes separately and for 1 hour jointly to draft a comprehensive and coordinated set of recommendations for a research agenda. . Irene Andrulis, The Ontario Cancer Treatment and Research Foundation Dr. Will Genetic Testing for Breast Cancer Risk Help Control Breast Cancer. Community Perspective and Religious Values Rabbi Avis Miller, Adas Israel Congregation, Washington, D.</td>
<tr>
</table>
<br>also look at: <a href="http://www.med.upenn.edu/abramson/cancer_gen.html">http://www.med.upenn.edu/abramson/cancer_gen.html</a><br><br>
</font><font size=-6> <a class="nav" href="">.</a><br><br>
</font></body></html>
